Skip to main content

Matinas BioPharma Holdings, Inc.

MTNB
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001582554

No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.

Members of Congress who traded MTNB

No member of Congress has reported a trade in Matinas BioPharma Holdings, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.